Elevian Announces $15 Million Equity Financing

Company Expands Leadership Team as it Advances Preclinical Studies of rGDF11 in Stroke and Other Age-Related Diseases ALLSTON, Mass., Nov. 24, 2020 -- (Healthcare Sales & Marketing Network) -- Elevian, an emerging biotech company developing medicines t... Biopharmaceuticals, Regenerative Medicine, Venture Capital Elevian, age-related disease, GDF11
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news